• Result of Annual General Meeting

    Read more
  • Redx to Exhibit Three Posters at AACR Annual Meeting

    Read more
  • First Participant Dosed in Phase 1 Trial of RXC008

    Read more
  • Redx to Present at Cowen Health Care Conference

    Read more
  • Redx announces sale of KRAS inhibitor program

    Read more
  • Redx Annual Results December 2023

    Read more
  • Admission of Subscription Shares and TVR

    Read more
  • Results of General Meeting

    Read more
  • Redx Unveils Preclinical Data from RXC009

    Read more
  • Redx to present preclinical data on RXC009 at ASN

    Read more